Clinical Trial Update: A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET) [Phase 3]

View source ↗

Summary

Phase 3 trial of CD07743 for improvement of lateral canthal lines (crow's feet) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Canthal Lines

Drugs mentioned

• CD07743

Snippet

Sponsor: Galderma R&D | Conditions: Canthal Lines | Phase 3 | Status: COMPLETED | Results posted: 2020-05-01